TECTA Gene Deafness Autosomal Dominant Type 12 Genetic Test sale cost 4400 AED
GJB2 Gene Deafness with Keratopachydermia and Constrictions of Fingers and Toes Genetic Test sale cost 4400 AED GJB2 Gene Deafness with Keratopachydermia and Constrictions of Fingers and Toes Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
CCDC50 Gene Deafness Autosomal Dominant Type 44 Genetic Test sale cost 4400 AED CCDC50 Gene Deafness Autosomal Dominant Type 44 Genetic Test 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

TECTA Gene Deafness Autosomal Dominant Type 12 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TECTA Gene Deafness Autosomal Dominant Type 12 Genetic Test is a specialized diagnostic tool used to identify mutations in the TECTA gene, which can lead to autosomal dominant non-syndromic hearing loss, specifically categorized as type 12. This form of hearing loss is characterized by its genetic inheritance pattern, where a single copy of the altered gene in each cell is sufficient to cause the condition. The TECTA gene is crucial for the proper development and function of the inner ear, which plays a significant role in the ability to hear.

Conducted at DNA Labs UAE, this genetic test is designed to provide individuals and families with crucial information regarding the genetic basis of their hearing loss, facilitating early diagnosis and intervention strategies. With a cost of 4400 AED, the test is a valuable resource for those with a family history of hearing loss or for individuals experiencing hearing difficulties, aiming to understand the genetic underpinnings of their condition. By identifying specific mutations in the TECTA gene, healthcare providers can offer more personalized management plans and genetic counseling, helping affected individuals and their families navigate the challenges associated with hearing loss.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

TECTA Gene Deafness Autosomal Dominant Type 12 Genetic Test

At DNA Labs UAE, we offer the TECTA Gene Deafness Autosomal Dominant Type 12 Genetic Test. This test is designed to diagnose individuals with hearing loss and identify mutations or variations in the TECTA gene that may be responsible for the condition.

Test Details

TECTA gene deafness, autosomal dominant type 12 is a type of genetic deafness caused by mutations in the TECTA gene. The TECTA gene provides instructions for making a protein called alpha-tectorin, which is essential for the normal functioning of the inner ear.

NGS (Next-Generation Sequencing) genetic testing is used in this test. It is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of TECTA gene deafness, autosomal dominant type 12, NGS genetic testing can identify mutations or variations in the TECTA gene that may be responsible for the hearing loss.

Our test is conducted using NGS Technology, and the results are delivered within 3 to 4 weeks. The cost of the test is 4400.0 AED.

Sample Condition

We accept blood or extracted DNA samples for this test. Alternatively, you can provide one drop of blood on an FTA Card.

Doctor and Test Department

This test is performed by an ENT Doctor in our Genetics Test Department.

Pre Test Information

Prior to the test, we require the clinical history of the patient who is going for the IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. We also recommend a Genetic Counselling session to draw a pedigree chart of family members affected with the IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS3.

Importance of Genetic Testing

It is crucial to note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics. The results of genetic testing can provide valuable information for individuals and families affected by TECTA gene deafness, autosomal dominant type 12, including accurate diagnosis, prognosis, and potential treatment options.

At DNA Labs UAE, we prioritize the well-being of our patients and ensure that our testing services are conducted with the utmost care and accuracy.

Test Name TECTA Gene Deafness autosomal dominant type 12 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS3
Test Details

TECTA gene deafness, autosomal dominant type 12 is a type of genetic deafness caused by mutations in the TECTA gene. The TECTA gene provides instructions for making a protein called alpha-tectorin, which is essential for the normal functioning of the inner ear.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic test that uses advanced sequencing technologies to analyze multiple genes simultaneously. In the case of TECTA gene deafness, autosomal dominant type 12, NGS genetic testing can be used to identify mutations or variations in the TECTA gene that may be responsible for the hearing loss.

NGS genetic testing for TECTA gene deafness, autosomal dominant type 12 can help in the diagnosis of individuals with hearing loss and can also be used for carrier testing and prenatal testing in families with a known TECTA gene mutation.

It is important to note that genetic testing should be performed and interpreted by qualified healthcare professionals who specialize in genetics. The results of genetic testing can provide valuable information for individuals and families affected by TECTA gene deafness, autosomal dominant type 12, including accurate diagnosis, prognosis, and potential treatment options.

SKU: TEST-2674 Category:

Related products